It is possible to classify non-erosive reflux disease (NERD) patients into endoscopically normal groups and minimal change groups by subjective symptoms and responsiveness to rabeprazole-a report from a study with japanese patients (Digestive Diseases and Sciences DOI: 10.1007/s10620-008-0290-2);It is possible to classify non-erosive reflux disease (NERD) patients into endoscopically normal groups and minimal change groups by subjective symptoms and responsiveness to rabeprazole - A report from a study with Japanese patients

Digestive Diseases and Sciences

Volumn 53, Issue 12, 2008, Pages 3082-3094

  Kusano, Motoyasu ^a,s   Shirai, Naohito ^b   Yamaguchi, Kanako ^c   Hongo, Michio ^d,s   Chiba, Tsutomu ^e,s   Kinoshita, Yoshikazu ^f,s   Ohara, Shuichi ^d,s   Hoshihara, Yoshio ^g,s   Kurosawa, Susumu ^h,s   Watanabe, Yusuke ^i,s   Furuta, Takahisa ^j,s   Joh, Takashi ^k,s   Higuchi, Kazuhide ^l,s   Fujiwara, Yasuhiro ^m,s   Habu, Yasuki ^n,s   Miwa, Hiroto ^o,s   Haruma, Ken ^p,s   Manabe, Noriaki ^p,s   Adachi, Kyoichi ^f,s   Shimatani, Tomohiko ^q,s   Ito, Masanori ^r,s   Fujimoto, Kazuma ^c,s   more..

^a GUNMA UNIVERSITY HOSPITAL   (Japan)

^b Enshu Hospital   (Japan)

^c SAGA UNIVERSITY   (Japan)

^d TOHOKU UNIVERSITY HOSPITAL   (Japan)

^e KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^g Ministry of International Trade and Industry   (Japan)

^h SAITAMA MEDICAL UNIVERSITY   (Japan)

ⁱ International University of Health and Welfare Mita Hospital   (Japan)

^j HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^l OSAKA MEDICAL COLLEGE   (Japan)

^m OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁿ Saiseikai Noe Hospital   (Japan)

^o HYOGO COLLEGE OF MEDICINE   (Japan)

^p KAWASAKI MEDICAL SCHOOL   (Japan)

^q HIROSHIMA INTERNATIONAL UNIVERSITY   (Japan)

^r HIROSHIMA UNIVERSITY   (Japan)

^s NONE

more..

Author keywords

Minimal change; NERD; Questionnaire; Rabeprazole; Symptom

Indexed keywords

RABEPRAZOLE;

ADULT; ARTICLE; BLOATING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HEARTBURN; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON EROSIVE REFLUX DISEASE; PRIORITY JOURNAL; QUESTIONNAIRE; STOMACH MOTILITY; STOMACH PAIN; SYMPTOMATOLOGY; TREATMENT RESPONSE;

EID: 55949111032     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-008-0636-9     Document Type: Erratum

References (30)

1. J Dent J Brun A Fendrick M Fennerty J Janssens P Kahrilas K Lauritsen J Reynolds M Shaw N Talley The Genval Workshop Group 1999 An evidence-based appraisal of reflux disease management-the Genval Workshop Report Gut 44 Suppl 2 S1 16
2. N Vakil SV van Zanten P Kahrilas J Dent R Jones Global Consensus Group 2006 The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus Am J Gastroenterol 101 1900 1920
3. N Chiba CJ De Gara JM Wilkinson RH Hunt 1997 Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta analysis Gastroenterology 112 1798 1810
4. B van Pixteren ME Numans PA Bonis J Lau 2006 Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease Cochrane Database Syst Rev 19 CD002095
5. DA Tendler RA Parker SJ Spechler 1996 Heartburn: ethnic variations in prevalence and interpretation Gastroenterology 110 A276
6. R Fass 2003 Epidemiology and pathophysiology of symptomatic gastroesophageal reflux disease Am J Gastroenterol 98 Suppl 3 S2 S7
7. CM Bate JR Green AT Axon FE Murray G Tildesley CE Emmas MD Taylor 1997 Omeprazole is more effective than cimetidine for the relief of all grades of gastro-oesophageal reflux disease-associated heartburn, irrespective of the presence or absence of endoscopic oesophagitis Aliment Pharmacol Ther 11 755 763
8. TL Venables RD Newland AC Patel J Hole C Wilcock ML Turbitt 1997 Omeprazole 10 milligrams once daily, Omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease-in general practice Scand J Gastroenterol 32 765 773
9. M Kusano Y Shimoyama S Sugimoto O Kawamura M Maeda K Minashi S Kuribayashi T Higuchi H Zai K Ino T Horikoshi T Sugiyama M Toki T Ohwada M Mori 2004 Development and evaluation of FSSG; frequency scale for the symptoms of GERD J Gastroenterol 39 888 891
10. K Adachi Y Matsumori T Fujisawa T Kamada M Kusaka T Ohumi R Iwakiri K Yamaguchi A Danjo K Hori T Tomita T Hayashi K Haruma K Fujimoto H Miwa Y Kinoshita 2006 Symptom diversity of patients with reflux esophagitis: effect of omeprazole treatment J Clin Biochem Nutr 39 46 54
11. PJ Kahrilas 2003 Diagnosis of symptomatic gastroesophageal reflux disease Am J Gastroenterol 98 Suppl 3 S15 S23
12. Y Hoshihara 2004 Endoscopic findings of GERD Nippon Rinsho 62 1459 1464
13. T Nakamura K Shirakawa H Masuyama H Sugaya H Hiraishi A Terano 2005 Minimal change oesophagitis: a disease with characteristic differences to erosive oesophagitis Aliment Pharmacol Ther 21 19 26
14. M Hongo 2006 Minimal changes in reflux esophagitis: red ones and white ones J Gastroenterol 41 95 99
15. P Miner W Orr J Filippone L Jokubaitis S Sloan 2002 Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial Aliment Pharmacol Ther 97 1332 1339
16. KM Fock EK Teo TL Ang TS Chua TM Ng YL Tan 2005 Rabeprazole vs. esomeprazole in non-erosive gastro-esophageal reflux disease: a randomized, double-blind study in urban Asia World J Gastroenterol 11 3091 3098
17. K Adachi T Hashimoto N Hamamoto K Hirakawa M Niigaki T Miyake H Taniura M Ono T Kaji H Suetsugu J Yagi Y Komazawa T Mihara T Katsube H Fujishiro T Shizuku S Hattori S Yamamoto Y Kinoshita 2003 Symptom relief in patients with reflux esophagitis: comparative study of omeprazole, lansoprazole, and rabeprazole J Gastroenterol Hepatol 18 1392 1398
18. M Robinson S Fitzgerald R Hegedus A Murthy L Jokubaitis FAST Trial Investigators 2002 Onset of symptom relief with rabeprazole: a community-based, open-label assessment of patients with erosive oesophagitis Aliment Pharmacol Ther 16 445 454
19. G Holtmann P Bytzer M Metz V Loeffler AL Blum 2002 A randomized, double-blind, comparative study of standard-dose rabeprazole and high-dose omeprazole in gastro-oesophageal reflux disease Aliment Pharmacol Ther 16 479 485
20. Y Fujiwara K Higuchi M Shiba K Yamamori Y Watanabe E Sasaki K Tominaga T Watanabe N Oshitani T Arakawa 2005 Differences in clinical characteristics between patients with endoscopy-negative reflux disease and erosive esophagitis in Japan Am J Gastroenterol 100 754 758
21. GR Locke III NJ Talley SL Fett AR Zinsmeister LJ Melton III 1997 Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota Gastroenterology 112 1448 1456
22. KJ Lee R Vos J Janssens J Tack 2004 Influence of duodenal acidification on the sensorimotor function of the proximal stomach in humans Am J Physiol Gastrointest Liver Physiol 286 G278 G284
23. RH Jones G Baxter 1997 Lansoprazole 30 mg daily versus ranitidine 150 mg b.d. in the treatment of acid-related dyspepsia in general practice Aliment Pharmacol Ther 11 541 546
24. RH Jones SL Crouch 1999 Low-dose lansoprazole provides greater relief of heartburn and epigastric pain than low-dose omeprazole in patients with acid-related dyspepsia Aliment Pharmacol Ther 13 413 419
25. T Joh H Miwa K Higuchi T Shimatani N Manabe K Adachi T Wada M Sasaki Y Fujiwara M Hongo T Chiba Y Kinoshita ARS Research Group 2007 Validity of endoscopic classification of nonerosive reflux disease J Gastroenterol 42 444 449
26. J Keohane EM Quigley 2006 Functional dyspepsia and non-erosive reflux disease: a review Minerva Gastroenterol Dietol 52 261 267
27. EM Quigley 2004 Functional dyspepsia (FD) and non-erosive reflux disease (NERD): overlapping or discrete entities? Best Pract Res Clin Gastroenterol 18 695 706
28. H Suzuki T Nishizawa T Hibi 2006 Therapeutic strategies for functional dyspepsia and the introduction of the Rome III classification J Gastroenterol 41 513 523
29. J Tack NJ Talley M Camilleri G Holtmann P Hu JR Malagelada V Stanghellini 2006 Functional gastroduodenal disorders Gastroenterology 130 1466 1479
30. Y Shimoyama M Kusano S Sugimoto O Kawamura M Maeda K Minashi S Kuribayashi T Higuchi H Zai K Ino T Horikoshi F Moki T Sugiyama M Toki T Ohwada M Mori 2005 Diagnosis of gastroesophageal reflux disease using a new questionnaire J Gastroenterol Hepatol 20 643 7